Blog Posts in 2009
Posted on Nov 20, 2009 By DeCarli Law
The European Medicines Agency (EMEA) issued a press release today, stating that it would begin classifying gadolinium-based contrast agents into three risk categories based on their likelihood of ...
Continue reading "European Health Agency to Label Gadolinium-Based Contrast Agents as High-, Medium-, or Low-Risk for Causing NSF" »
Posted on Nov 17, 2009 By DeCarli Law
In a recently-prepared FDA document, staff members conclude that Omniscan , Magnevist , and OptiMARK are the gadolinium-based contrast agents with the highest risk of causing Nephrogenic Systemic ...
Continue reading "FDA Staff: Omniscan, Magnevist and OptiMARK Gadolinium-Based Contrast Agents Most Likely to Cause NSF" »
Posted on Nov 12, 2009 By DeCarli Law
A recent settlement likely means more money to pay claims made by people whose kidneys failed after using Fleet Phospho-Soda and Fleet Phospho soda EZ Prep Bowel Cleansing System. Hundreds of people ...
Continue reading "Insurance Coverage for Fleet Phospho-Soda Injuries" »
Posted on Nov 10, 2009 By DeCarli Law
The New Jersey Law Journal has reported that New Jersey YAZ, Yasmin and Ocella lawsuits may be consolidated before a single judge. The New Jersey judiciary is considering a request from Judge Donald ...
Continue reading "Movement Toward Consolidation of New Jersey YAZ, Yasmin and Ocella Side Effect Lawsuits" »
Posted on Nov 10, 2009 By DeCarli Law
Mallinkrodt Inc., the manufacturer of gadolinium-based contrast agent OptiMARK, announced yesterday that it has submitted a label change that warns against any use of OptiMARK on patients with severe ...
Continue reading "New OptiMARK Label Warns Against Any Use on Patients with Severe Renal Failure" »
Posted on Nov 4, 2009 By DeCarli Law
A recent study indicates that UV-A1 phototherapy has promise for reducing symptoms of Nephrogenic Systemic Fibrosis (NSF) . Four patients with NSF were treated with UV-A1. The skin on all four ...
Continue reading "UV-A1 Therapy Promising for Nephrogenic Systemic Fibrosis (NSF)" »
Posted on Oct 28, 2009 By DeCarli Law
A recent clinical trial shows that the cancer drug Gleevec (generic name Imatinib Mesylate) helps lessen the skin symptoms of Nephrogenic Systemic Fibrosis (NSF) . The study was conducted by Dr. ...
Continue reading "Cancer Drug Gleevec Shows Promise for Treatment of Nephrogenic Systemic Fibrosis (NSF)" »
Posted on Oct 27, 2009 By DeCarli Law
A recently-published study concludes that larger and more frequent use of gadolinium-based contrast agents increases the risk of nephrogenic systemic fibrosis (NSF) . Patients who received higher ...
Continue reading "Larger Doses and Repeated Use of Gadolinium-Based Contrast Agents Increase Risk of Nephrogenic Systemic Fibrosis (NSF)" »
Posted on Oct 21, 2009 By DeCarli Law
In May 2007, the FDA ordered all manufacturers of gadolinium-based contrast agents to warn of the risk of Nephrogenic Systemic Fibrosis (NSF) for people with kidney disease. However, the FDA ...
Continue reading "FDA Considered Recommending that GE Gadolinium Contrast Agent Omniscan Never Be Used on Patients with Renal Failure" »
Posted on Oct 20, 2009 By DeCarli Law
Today, the United States Court of Appeals for the Eighth Circuit heard oral argument on whether a failure to warn claim against a generic drug manufacturer is preempted. We discussed this legal issue ...
Continue reading "8th Circuit Considers Preemption of Injury Claims Against Generic Drug Manufacturers" »
Posted on Oct 20, 2009 By DeCarli Law
Federal regulators plan to meet in December to review a 2007 decision to issue a blanket warning about the risks of special imaging drugs that are injected as part of MRI scans. The U.S. Food and Drug ...
Continue reading "FDA to Take a Second Look at Warnings on MRI Drugs" »
Posted on Oct 19, 2009 By Bob DeCarli
On October 1, 2009, the United States Judicial Panel on Multidistrict Litigation issued an order consolidating lawsuits involving YAZ, Yasmin and Ocella birth control pills . The YAZ multidistrict ...
Continue reading "Multidistrict Litigation (“MDL”) Court Created for YAZ Birth Control Lawsuits" »
Posted on Oct 18, 2009 By DeCarli Law
We often hear that generic drugs are the same as name brand drugs, only they cost less. But not according to drug manufacturers. Drug companies are currently arguing to courts around the country that ...
Continue reading "Users of Generic Drugs May Have Less Rights When Injured" »
Posted on Oct 7, 2009 By DeCarli Law
The optimistic sounding conclusion of a recent study on the safety of gadolinium-based contrast agents is misleading to the extent it fails to address the risk of Nephrogenic Systemic Fibrosis (NSF) , ...
Continue reading "Mayo Clinic Study Ignores Risk of Nephrogenic Systemic Fibrosis (NSF) From Gadolinium-Based Contrast Agents" »
Posted on Oct 1, 2009 By Bob DeCarli
An internet search for the phrase “MRI lawsuit” will pull up various law-firm and attorney-sponsored websites. The term “MRI lawsuit,” however, is misleading. Magnetic resonance imaging (MRI) itself ...
Continue reading "The Term "MRI Lawsuit" is Misleading" »
Posted on Sep 28, 2009 By DeCarli Law
Nephrogenic systemic fibrosis (NSF) , also known as nephrogenic fibrosing dermopathy (NFD) , can be difficult to distinguish from other fibrosing skin disorders. However, according to a recent study, ...
Continue reading "Lower Leg Skin Symptoms Can Distinguish Nephrogenic Systemic Fibrosis (NSF) From Other Fibrosing Disorders" »
Posted on Sep 25, 2009 By DeCarli Law
The most common symptom of nephrogenic systemic fibrosis (NSF) is a thickening and hardening of the skin, usually on the lower legs or forearms. However, not all people have the same skin symptoms, ...
Continue reading "Skin Symptoms Vary Widely for Nephrogenic Systemic Fibrosis (NSF)" »
Posted on Sep 22, 2009 By Bob DeCarli
Because nephrogenic systemic fibrosis (NSF) , also known as nephrogenic fibrosing dermopathy (NFD) , is a new disease, it is often misdiagnosed or goes undiagnosed. Even worse, dialysis patients and ...
Continue reading "Nephrogenic Systemic Fibrosis: A Frequently Undiagnosed and Misdiagnosed Disease" »
Posted on Sep 17, 2009 By DeCarli Law
Welcome to DeCarli Law. We launch this blog with the commitment to provide up-to-date information about the latest warnings and recalls about dangerous drugs, as well as other medical and legal news ...
Continue reading "Welcome " »